Radiopharm Theranostics Limited (ASX:RAD) Insider Acquires A$87,000.00 in Stock

Radiopharm Theranostics Limited (ASX:RAD) insider Ian Turner acquired 3,000,000 shares of the firm’s stock in a transaction on Friday, May 23rd. The stock was purchased at an average price of A$0.03 ($0.02) per share, with a total value of A$87,000.00 ($56,493.51).

Radiopharm Theranostics Price Performance

The stock has a market cap of $60.78 million, a P/E ratio of -0.19 and a beta of 0.82.

Radiopharm Theranostics Company Profile

Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It is developing its lead products comprising Nano-mAbs and AVB6 Integrin. The company was incorporated in 2021 and is based in Carlton, Australia.